Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Meta-hallmarks of aging and cancer
2023
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
2009
A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma
2013
Glycoproteomic Analysis of the Secretome of Human Endothelial Cells
2013
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma
2008
A global perspective on cadmium pollution and toxicity in non-occupationally exposed population
2002
Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design
2012
Haloperidol dose for the acute phase of schizophrenia
2002
From NASH to HCC: current concepts and future challenges
2019
Direct Cell Surface Modification with DNA for the Capture of Primary Cells and the Investigation of Myotube Formation on Defined Patterns
2009 StandoutNobel
Rapamycin Ameliorates Kidney Fibrosis by Inhibiting the Activation of mTOR Signaling in Interstitial Macrophages and Myofibroblasts
2012
TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON
2016
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Thrombotic and Bleeding Complications of Prosthetic Heart Valves
1987
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
2018
Toward better outcomes with tacrolimus therapy: Population pharmacokinetics and individualized dosage prediction in adult liver transplantation
2003
Cadmium activates the mitogen-activated protein kinase (MAPK) pathway via induction of reactive oxygen species and inhibition of protein phosphatases 2A and 5
2008
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis
2016
Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”
2012
Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process
2014
Hallmarks of aging: An expanding universe
2023 Standout
Hepatocellular carcinoma
2012 Standout
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Isotope-targeted glycoproteomics (IsoTaG): a mass-independent platform for intact N- and O-glycopeptide discovery and analysis
2015 StandoutNobel
Chemoembolization With Doxorubicin-Eluting Beads for Unresectable Hepatocellular Carcinoma: Five-Year Survival Analysis
2012
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies
2008
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
2016
POPULATION PHARMACOKINETICS OF TACROLIMUS IN CHILDREN WHO RECEIVE CUT-DOWN OR FULL LIVER TRANSPLANTS
2001
Transarterial radioembolizationvschemoembolization for hepatocarcinoma patients: A systematic review and meta-analysis
2016
Covariate Effects on the Apparent Clearance of Tacrolimus in Paediatric Liver Transplant Patients Undergoing Conversion Therapy
2001
Acute kidney injury
2019 Standout
Macrophages in Tissue Repair, Regeneration, and Fibrosis
2016 Standout
Liver cancer: Approaching a personalized care
2015
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
2016
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion
2016
Establishment of the Reference Intervals of Lymphocyte Function in Healthy Adults Based on IFN-γ Secretion Assay upon Phorbol-12-Myristate-13-Acetate/Ionomycin Stimulation
2018
Transarterial therapies for hepatocellular carcinoma
2011
Diagnosis and management of adrenal insufficiency
2014
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
Loco‐regional treatment of hepatocellular carcinoma†
2010
EMT: 2016
2016 Standout
Management of HCC
2012
Tacrolimus
1997
Cadmium Accumulation in Liver and Kidneys and Hepatic Metallothionein and Glutathione Levels in Rana ridibunda, After Exposure to CdCl2
1998
Biomarkers of Drug-Induced Kidney Toxicity
2018
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy
2017
Heavy Metal Toxicity and the Environment
2012 Standout
Pharmacodynamics of T‐cell function for monitoring immunosuppression
2007
Treatment of intermediate-stage hepatocellular carcinoma
2014
Local-Regional Treatment of Hepatocellular Carcinoma
2011
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
2014
Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma
2009
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Transarterial embolization with or without chemotherapy for advanced hepatocellular carcinoma: a systematic review
2014
Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients
2015
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study
2011
Reactive oxygen species, cellular redox systems, and apoptosis
2010 Standout
Hepatocellular Carcinoma
2011 Standout
German Environmental Survey 1998 (GerES III): environmental pollutants in blood of the German population
2002
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Treatment of Hepatocellular Carcinoma
2016
The roles of C4 and AUC0–4 in monitoring of tacrolimus in stable kidney transplant patients
2002
Immunotherapy in Elderly Transplant Recipients
2009
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Metabolites Are Key to Understanding Health Effects of Wine Polyphenolics
2009
Improved stability of lipiodol–drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicin
2015
Tacrolimus-Associated Posterior Reversible Encephalopathy Syndrome after Solid Organ Transplantation
2010
Hepatocellular carcinoma
2022 Standout
Targeted Therapies for Hepatocellular Carcinoma
2011
Hepatocellular carcinoma: clinical frontiers and perspectives
2014
Pesticides and breast cancer risk: a review of DDT, DDE, and dieldrin.
2001
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Development of IsoTaG, a Chemical Glycoproteomics Technique for Profiling Intact N- and O-Glycopeptides from Whole Cell Proteomes
2017 StandoutNobel
Impairment of schedule-controlled behavior by pre- and postnatal exposure to hexachlorobenzene in rats
1996
Overall Survival After Transarterial Lipiodol Infusion Chemotherapy With or Without Embolization for Unresectable Hepatocellular Carcinoma: Propensity Score Analysis
2010
Diabetic Cardiomyopathy
2018 Standout
Metabolism of hexachlorobenzene in humans: association between serum levels and urinary metabolites in a highly exposed population.
1997
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Silk Embolic Material for Catheter‐Directed Endovascular Drug Delivery
2021
Haloperidol dose for the acute phase of schizophrenia
2013
Transarterial Chemoembolization and Radioembolization
2014
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Urinary Creatinine Concentrations in the U.S. Population: Implications for Urinary Biologic Monitoring Measurements
2004 Standout
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
2010
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
Superoxide Ion: Generation and Chemical Implications
2016 Standout
The Timing of Normal Puberty and the Age Limits of Sexual Precocity: Variations around the World, Secular Trends, and Changes after Migration
2003 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Identification of drugs as single agents or in combination to prevent carcinoma dissemination in a microfluidic 3D environment
2015
Reshaping de Novo Protein Switches into Bioresponsive Materials for Biomarker, Toxin, and Viral Detection
2022 StandoutNobel
A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation
2013
Analytical applications of chemiluminescence-detection systems assisted by magnetic microparticles and nanoparticles
2013
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
2020 Standout
Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models.
2000 Standout
Works of Merçè Brunet being referenced
Organochlorine residues in human adipose tissue of the population of Zaragoza (Spain)
1992
Positive versus negative symptoms in schizophrenia: Response to haloperidol
1994
Influence of posttransplant time on dose and concentration of tacrolimus in liver transplant patients
1998
Low-Dose Cyclosporine with Mycophenolate Mofetil Induces Similar Calcineurin Activity and Cytokine Inhibition as does Standard-Dose Cyclosporine in Stable Renal Allografts
2004
Cytokines as predictive biomarkers of alloreactivity
2012
The First Simultaneous Kidney–Adrenal Gland–Pancreas Transplantation: Outcome at 1 Year
2013
Cadmium and zinc relationships in the liver and kidney of humans exposed to environmental cadmium
1995
Therapeutic drug monitoring of tacrolimus in kidney transplantation: 9-month follow–up
1998
Mammalian Target of Rapamycin Inhibition Halts the Progression of Proteinuria in a Rat Model of Reduced Renal Mass
2007
Effect of Mycophenolate Mofetil on Immune Response and Plasma and Lymphatic Tissue Viral Load During and After Interruption of Highly Active Antiretroviral Therapy for Patients With Chronic HIV Infection
2004
Pharmacokinetic and pharmacodynamic correlations of cyclosporine therapy in stable renal transplant patients: evaluation of long-term target C2
2003
A first-in-human phase I/Ib dose-escalation clinical trial of the autophagy inducer ABTL0812 in patients with advanced solid tumours
2021
Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics
2006
Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus
2006
Biomarker Assessment of the Immunomodulator Effect of Atorvastatin in Stable Renal Transplant Recipients and Hypercholesterolemic Patients
2010
Therapeutic Drug Monitoring of Tacrolimus in Liver Transplantation, Phase III FK506 Multicenter Spanish Study Group: A Two-Year Follow-Up
1998
Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference
2009
The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy
2009
Proteomic analysis of the secretome of human umbilical vein endothelial cells using a combination of free‐flow electrophoresis and nanoflow LC‐MS/MS
2009
Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation
2016
Comparative Analysis of Tacrolimus (FK506) in Whole Blood Liver Transplant Recipients by PRO-TRAC Enzyme-Linked Immunosorbent Assay and Microparticle Enzyme Immunoassay IMX Methods
1996
Accumulation of hexachlorobenzene in humans: a long standing risk
1995
Influence of posttransplant time on dose and concentration of tacrolimus in liver transplant patients
1998
Systemic thromboembolic accidents in the early post-operative period in patients with prosthetic valves
1984
Human Apo A-I and Rat Transferrin Are the Principal Plasma Proteins That Bind Wine Catechins
2002
Total and metallothionein-bound cadmium in the liver and the kidney of a population in Barcelona (Spain)
1994